
Personalised medicine to relieve the health service
Smaller patient groups and targeted treatments are the future of cancer care in Norway.
Meet the innovators: Start-up stories from Oslo Cancer Cluster.
Did you know we have a YouTube channel?
May 5, 2025
Dave Tippett
There’s no shortage of groundbreaking science in Oslo Cancer Cluster – and now, you can meet the minds behind the mission on our YouTube Member Videos playlist. In this new video series, our members give quickfire introductions to who they are, what they’re building, and how they’re changing the future of cancer diagnostics, data, and digital tools.
Whether you’re a researcher, investor, clinician, or just curious about the next wave of oncology innovation—this playlist is your backstage pass.
Here’s a glimpse of three exciting start-ups featured in our latest spotlight:
Do More Diagnostics is revolutionising how we use routine histopathology slides. Their technology adds powerful prognostic insights using digital biomarkers and AI, helping clinicians decide which colon cancer patients truly need chemotherapy. It’s a brilliant example of “do more” with what you already have.
Data matters—but only if we can use it. NordicRWE is making real-world evidence (RWE) accessible and actionable for researchers and health decision-makers. By streamlining access to high-quality health data, they help bridge the gap between research, regulation, and real-life clinical practice. The result? Faster, smarter decisions that improve patient care.
Hospitals are busy places. Diffia builds digital solutions like its flagship product, Nimble, to lighten the clinical load. Designed for healthcare professionals by healthcare professionals, Nimble helps streamline communication and daily routines in Norwegian hospitals—freeing up time for what matters most: patient care.
These are just a few of the many trailblazers in our member community. Check out the full playlist, hit subscribe, and keep an eye out as we continue to highlight the people transforming cancer care—one video at a time.
Watch the entire Member Video Playlist on YouTube.
Smaller patient groups and targeted treatments are the future of cancer care in Norway.
Geir Hetland, Chief Financial Officer of Thermo Fisher Scientific, is the latest addition to the board of Oslo Cancer Cluster.